Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Bio Essence (BIOE) Income from Continuing Operations (2020 - 2025)

Bio Essence has reported Income from Continuing Operations over the past 6 years, most recently at 1029087.0 for Q4 2025.

  • For Q4 2025, Income from Continuing Operations rose 3833.58% year-over-year to 1029087.0; the TTM value through Dec 2025 reached 896197.0, up 157.24%, while the annual FY2025 figure was 896197.0, 157.24% up from the prior year.
  • Income from Continuing Operations for Q4 2025 was 1029087.0 at Bio Essence, up from 12998.0 in the prior quarter.
  • Over five years, Income from Continuing Operations peaked at 1029087.0 in Q4 2025 and troughed at 1199493.0 in Q3 2024.
  • A 5-year average of 112478.7 and a median of 143262.0 in 2021 define the central range for Income from Continuing Operations.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 1041.83% in 2024 and later surged 3833.58% in 2025.
  • Year by year, Income from Continuing Operations stood at 90634.0 in 2021, then surged by 175.76% to 68664.0 in 2022, then crashed by 366.59% to 183048.0 in 2023, then soared by 84.94% to 27563.0 in 2024, then surged by 3833.58% to 1029087.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for BIOE at 1029087.0 in Q4 2025, 12998.0 in Q3 2025, and 59864.0 in Q2 2025.